Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lytus Technologies is a publicly traded technology platform company with operations spanning media and entertainment, broadband, fintech, cloud, AI/ML, and HealthTech. In healthcare, the company focuses on digital health infrastructure rather than drug development, offering AI-enabled telemedicine, diagnostics, care-pathway support, and medical logistics solutions. Its HealthTech business includes Lytus Blod, a blood component management and logistics platform intended to improve blood supply availability, reduce procurement times, and optimize inventory through predictive analytics. The company primarily serves users in India and has stated ambitions to expand selected HealthTech services internationally, including to the U.S. and UAE. Overall, Lytus is best characterized as a diversified tech-enabled services company with a commercial-stage digital health business, not a biotech or pharmaceutical therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lytus Technologies.